Fertility-sparing Surgery

2

Review clinical trials related to Fertility-sparing Surgery. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Multi-center Prospective Study on the Oncological and Reproductive Outcomes and Quality of Life in Young Woman After Fertility-sparing Treatment of Endometrial Cancer and Endometrial Intraepithelial Hyperplasia

We will investigate the safety and efficiency of fertility-sapring treatment in ypung women witg endometrial cancer and endometrial intraepithelial hyperplasia

Participants needed: 100
Trial details
Age: 18-45Biological sex: FemaleType: ObservationalSponsor: Region StockholmUpdated: Dec 20, 2024
Eligibility criteria

Fertility sparing treatment of EC and EIN. [+3]

Not English och Swedish speaking

Status: Recruiting

Phase II Study on Neoadjuvant Therapy of AK104 Combined With Nab-paclitaxel/Carboplatin in Fertility Preserving Surgery

This is a Phase II study of neoadjuvant therapy of AK104 combined with nab-paclitaxel/carboplatin in fertility saving surgery for stage IB2-IB3 cervical cancer (FIGO 2018). The main questions it aims to answer are: * · Evaluate the safety of AK104 combined with nab-paclitaxel/carboplatin in the neoadjuvant treatment of cervical cancer * · Evaluate the tumor regression and Major Pathological Response(MPR) of AK104 combined with nab-paclitaxel/carboplatin as neoadjuvant therapy for cervical cancer.

Participants needed: 30
Trial details
Phase: Phase 2Age: 18-45Biological sex: FemaleType: InterventionalSponsor: Xiaohua WuUpdated: Jan 17, 2024Locations: 1
Eligibility criteria

Voluntarily sign a written ICF. [+12]

The histopathological types are small cell carcinoma, gastric adenocarcinoma, et... [+21]